Use of imidazolinone derivative combined with doxorubicin in treatment of tumors

TW202641549APending Publication Date: 2026-10-16KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115126832
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-07-20
Filing Date
2023-07-19
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001081454_001
    Figure TWG2TA001081454_001
  • Figure TWG2TA001081454_002
    Figure TWG2TA001081454_002
Patent Text Reader

Abstract

Provided is a use of a compound represented by general formula (I) in combination with doxorubicin in the preparation of an anti-cancer drug.
Need to check novelty before this filing date? Find Prior Art